Evidence map›Paper›PMID 24722281›Full record

ArticleCell death & disease2014

CGP37157, an inhibitor of the mitochondrial Na+/Ca2+ exchanger, protects neurons from excitotoxicity by blocking voltage-gated Ca2+ channels.

A Ruiz, E Alberdi, C Matute

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mitochondrial CaNature metabolism · 2026
    Article
  6. Article
  7. Mitochondrial CaJournal of cellular physiology · 2025
    Review
  8. Review
  9. Rescue of a Rotenone Model of Parkinson's Disease inInternational journal of molecular sciences · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Mitochondrial CaCells · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

A Ruiz1] Departamento de Neurociencias, Universidad del País Vasco-UPV/EHU, Barrio Sarriena s/n, Leioa, Spain [2] Achucarro Basque Center for Neuroscience-UPV/EHU, Zamudio, Spain [3] Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, (CIBERNED), Leioa, Spain.
E Alberdi1] Departamento de Neurociencias, Universidad del País Vasco-UPV/EHU, Barrio Sarriena s/n, Leioa, Spain [2] Achucarro Basque Center for Neuroscience-UPV/EHU, Zamudio, Spain [3] Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, (CIBERNED), Leioa, Spain.
C Matute1] Departamento de Neurociencias, Universidad del País Vasco-UPV/EHU, Barrio Sarriena s/n, Leioa, Spain [2] Achucarro Basque Center for Neuroscience-UPV/EHU, Zamudio, Spain [3] Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, (CIBERNED), Leioa, Spain.
University of the Basque Country · ESAchucarro Basque Center for Neuroscience · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibition of the mitochondrial Na(+)/Ca(2+) exchanger (NCLX) by CGP37157 is protective in models of neuronal injury that involve disruption of intracellular Ca(2+) homeostasis. However, the Ca(2+) signaling pathways and stores underlying neuroprotection by that inhibitor are not well defined. In the present study, we analyzed how intracellular Ca(2+) levels are modulated by CGP37157 (10 μM) during NMDA insults in primary cultures of rat cortical neurons. We initially assessed the presence of NCLX in mitochondria of cultured neurons by immunolabeling, and subsequently, we analyzed the effects of CGP37157 on neuronal Ca(2+) homeostasis using cameleon-based mitochondrial Ca(2+) and cytosolic Ca(2+) ([Ca(2+)]i) live imaging. We observed that NCLX-driven mitochondrial Ca(2+) exchange occurs in cortical neurons under basal conditions as CGP37157 induced a decrease in [Ca(2)]i concomitant with a Ca(2+) accumulation inside the mitochondria. In turn, CGP37157 also inhibited mitochondrial Ca(2+) efflux after the stimulation of acetylcholine receptors. In contrast, CGP37157 strongly prevented depolarization-induced [Ca(2+)]i increase by blocking voltage-gated Ca(2+) channels (VGCCs), whereas it did not induce depletion of ER Ca(2+) stores. Moreover, mitochondrial Ca(2+) overload was reduced as a consequence of diminished Ca(2+) entry through VGCCs. The decrease in cytosolic and mitochondrial Ca(2+) overload by CGP37157 resulted in a reduction of excitotoxic mitochondrial damage, characterized here by a reduction in mitochondrial membrane depolarization, oxidative stress and calpain activation. In summary, our results provide evidence that during excitotoxicity CGP37157 modulates cytosolic and mitochondrial Ca(2+) dynamics that leads to attenuation of NMDA-induced mitochondrial dysfunction and neuronal cell death by blocking VGCCs.

Indexed as

AnimalsCalciumCalcium Channel BlockersCalcium ChannelsCalpainCells, CulturedClonazepamCytoprotectionCytosolEndoplasmic ReticulumIntracellular SpaceMitochondriaNeuronsNeuroprotective AgentsNeurotoxinsN-MethylaspartateCalciumCalcium Channel BlockersCalcium ChannelsCalpainCGP 37157ClonazepamNeuroprotective AgentsNeurotoxinsN-MethylaspartateSodium-Calcium ExchangerThiazepines

Identifiers

PMID24722281
PMCPMC5424111
OpenAlexW1991078304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.